These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27167056)

  • 1. Reference Values for IGF-I Serum Concentrations: Comparison of Six Immunoassays.
    Chanson P; Arnoux A; Mavromati M; Brailly-Tabard S; Massart C; Young J; Piketty ML; Souberbielle JC;
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3450-8. PubMed ID: 27167056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reference values for IGF-I serum concentration in an adult population: use of the VARIETE cohort for two new immunoassays.
    Sabbah N; Wolf P; Piedvache C; Trabado S; Verdelet T; Cornu C; Souberbielle JC; Chanson P
    Endocr Connect; 2021 Aug; 10(9):1027-1034. PubMed ID: 34343107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of Patients With GH Disorders May Vary According to the IGF-I Assay.
    Mavromati M; Kuhn E; Agostini H; Brailly-Tabard S; Massart C; Piketty ML; Arnoux A; Young J; Souberbielle JC; Chanson P
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2844-2852. PubMed ID: 28505364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population.
    Granada ML; Ulied A; Casanueva FF; Pico A; Lucas T; Torres E; Sanmartí A
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):942-50. PubMed ID: 17980002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of immunoassays for the measurement of insulin-like growth factor-I and procollagen type III peptide, indirect biomarkers of recombinant human growth hormone misuse in sport.
    Abellan R; Ventura R; Pichini S; Pascual JA; Pacifici R; Di Carlo S; Bacosi A; Segura J; Zuccaro P
    Clin Chem Lab Med; 2005; 43(1):75-85. PubMed ID: 15653447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations.
    Bidlingmaier M; Friedrich N; Emeny RT; Spranger J; Wolthers OD; Roswall J; Körner A; Obermayer-Pietsch B; Hübener C; Dahlgren J; Frystyk J; Pfeiffer AF; Doering A; Bielohuby M; Wallaschofski H; Arafat AM
    J Clin Endocrinol Metab; 2014 May; 99(5):1712-21. PubMed ID: 24606072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of transferability between two automated immunoassays for serum IGF-I measurement.
    Gomez-Gomez C; Iglesias EM; Barallat J; Moreno F; Biosca C; Pastor MC; Granada ML
    Clin Lab; 2014; 60(11):1859-64. PubMed ID: 25648027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3).
    Elmlinger MW; Kühnel W; Weber MM; Ranke MB
    Clin Chem Lab Med; 2004; 42(6):654-64. PubMed ID: 15259383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of Reference Intervals for Serum Insulin-Like Growth Factor I in Korean Adult Population.
    Kim B; Cho Y; Ku CR; Lee SG; Lee KA; Kim JH
    Endocrinol Metab (Seoul); 2020 Dec; 35(4):960-964. PubMed ID: 33212546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reference ranges for an automated chemiluminescent assay for serum insulin-like growth factor I (IGF-I) in a large population of healthy adults from Buenos Aires.
    Guitelman M; Smithuis F; Garcia Basavilbaso N; Aranda C; Fabre B; Oneto A
    J Endocrinol Invest; 2015 Sep; 38(9):951-6. PubMed ID: 25740070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordance between mass spectrometry and immunometric IGF-1 assay in pituitary disease: a prospective study.
    Bonert V; Carmichael J; Wu Z; Mirocha J; Perez DA; Clarke NJ; Reitz RE; McPhaul MJ; Mamelak A
    Pituitary; 2018 Feb; 21(1):65-75. PubMed ID: 29218459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study.
    Brabant G; von zur Mühlen A; Wüster C; Ranke MB; Kratzsch J; Kiess W; Ketelslegers JM; Wilhelmsen L; Hulthén L; Saller B; Mattsson A; Wilde J; Schemer R; Kann P;
    Horm Res; 2003; 60(2):53-60. PubMed ID: 12876414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applicability of recently established reference values for serum insulin-like growth factor 1: A comparison of two assays--an (automated) chemiluminescence immunoassay and an enzyme-linked immunosorbent assay.
    Ivan D; Brabant G; Kann PH;
    Clin Lab; 2005; 51(7-8):381-7. PubMed ID: 16122148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordance of insulin-like growth factor-1 results and interpretation on four different platforms.
    Lee JKY; Cradic K; Singh RJ; Jones J; Li J
    Clin Chim Acta; 2023 Jan; 539():130-133. PubMed ID: 36528048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The introduction of the IDS-iSYS total IGF-1 assay may have far-reaching consequences for diagnosis and treatment of GH deficiency.
    Varewijck AJ; Lamberts SW; van der Lely AJ; Neggers SJ; Hofland LJ; Janssen JA
    J Clin Endocrinol Metab; 2015 Jan; 100(1):309-16. PubMed ID: 25337924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability among five different commercial IGF-1 immunoassays in conditions of childhood-onset GH deficiency and GH therapy.
    Anckaert E; Schiettecatte J; Vanbesien J; Smitz J; Velkeniers B; De Schepper J
    Acta Clin Belg; 2006; 61(6):335-9. PubMed ID: 17323843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: comparison with five widely used IGF-I immunoassays.
    Brugts MP; Ranke MB; Hofland LJ; van der Wansem K; Weber K; Frystyk J; Lamberts SW; Janssen JA
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2539-45. PubMed ID: 18397983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum insulin-like growth factor-I measurement in the follow-up of treated acromegaly: comparison of four immunoassays.
    Massart C; Poirier JY
    Clin Chim Acta; 2006 Nov; 373(1-2):176-9. PubMed ID: 16815351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reference levels of insulin-like growth factor I in the serum of healthy adults: comparison of four immunoassays.
    Ranke MB; Osterziel KJ; Schweizer R; Schuett B; Weber K; Röbbel P; Vornwald A; Blumenstock G; Elmlinger MW
    Clin Chem Lab Med; 2003 Oct; 41(10):1329-34. PubMed ID: 14580161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Insulin-like growth factor-1 levels of healthy adults in southern China.
    Liao ZH; Yin QQ; Wan JX; He W; Ji W; Zhang LY; Li YB
    Endocr J; 2016 Dec; 63(12):1081-1086. PubMed ID: 27569688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.